Previous 10 | Next 10 |
home / stock / mcujf / mcujf news
Medicure Files Patent Infringement Action Canada NewsWire WINNIPEG, Dec. 5, 2019 WINNIPEG , Dec. 5, 2019 /CNW/ - Medicure Inc. (" Medicure ") (TSXV: MPH, OTC: MCUJF), a cardiovascular pharmaceutical company, today announces that its subsidiary, Medicure International Inc....
The following slide deck was published by Medicure Inc. in conjunction with their 2019 Q3 earnings Read more ...
Start Time: 08:30 End Time: 08:48 Medicure Inc. (MCUJF) Q3 2019 Earnings Conference Call November 27, 2019, 08:30 AM ET Company Participants Albert Friesen - Chairman and CEO James Kinley - CFO Neil Owens - President and COO Conference Call Participants Presentation ...
Medicure ( OTCPK:MCUJF ): Q3 GAAP EPS of -C$0.04. More news on: Medicure Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
WINNIPEG , Nov. 26, 2019 /PRNewswire/ - Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, today reported its results from operations for the quarter ended September 30 , 2019. Quarter Ended September 30, 2019 ...
Medicure Q3 2019 Results and Conference Call Dates Canada NewsWire WINNIPEG, Nov. 19, 2019 WINNIPEG , Nov. 19, 2019 /CNW/ - Medicure Inc. ("Medicure" or the "Company") (TSXV: MPH, OTC: MCUJF), a cardiovascular pharmaceutical company, will release financial results for the...
WINNIPEG , Nov. 13, 2019 /PRNewswire/ - Medicure Inc. (" Medicure " or the " Company ") (TSXV: MPH, OTC: MCUJF), a cardiovascular pharmaceutical company, today announced the commencement of its previously announced substantial issuer bid (the " Offer "), pursuant to which the Company...
Medicure Announces Intention to Commence Substantial Issuer Bid Canada NewsWire WINNIPEG, Nov. 4, 2019 WINNIPEG , Nov. 4, 2019 /CNW/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, today announced its inte...
WINNIPEG , Oct. 15, 2019 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, is pleased to announce the primary results of the late-breaking SMILE TM -Heart Failure (SMILE-HF) Clinical Trial which was presented at the ...
WINNIPEG , Oct. 3, 2019 /PRNewswire/ - Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH, OTC:MCUJD.PK), a cardiovascular pharmaceutical company, is pleased to announce that it has reached a preferred pricing agreement with the AIDS Drug Assistance Program (ADAP) Crisis Task ...
News, Short Squeeze, Breakout and More Instantly...
WINNIPEG, MB / ACCESSWIRE / June 24, 2024 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today announces ...
WINNIPEG, MB / ACCESSWIRE / May 28, 2024 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported it...
Toto Ltd ADR (TOTDY) is expected to report for Q4 2024 NSK Ltd. ADR (NPSKY) is expected to report for Q4 2024 Monarch Cement Co. (MCEM) is expected to report for Q1 2024 HST Global Inc (HSTC) is expected to report for Q1 2024 Sumitomo Heavy Industries Ltd. ADR (SOHVY) is expected ...